Login to Your Account

Deals And M&A NEWS
SHANGHAI – Beike Biotechnology Co. Ltd., a pioneer in China's stem cell industry, has entered a partnership with Altor Bioscience Corp. in a two-part licensing and equity deal.
Gilead Sciences Inc. has signed licensing deals with seven Indian generic drugmakers to manufacture its flagship chronic hepatitis C virus (HCV) medicine, Sovaldi (sofosbuvir), and an investigational ledipasvir/sofosbuvir combination for distribution in 91 developing countries.
HONG KONG – With its latest deal to market vitamin D3 in Greater China, Lee's Pharmaceutical Holdings Ltd. is continuing along a growth path that has helped the company more than triple its share price in three years.
More Deals And M&A Headlines

Cast Your Vote

Has biotech’s bubble burst?: